1.A Case of Carcinosarcoma of Ovary.
Hyun Jin PARK ; Seung Pil LEE ; Jae Pyang SIM ; Heung Gon KIM ; Kie Jung YUN
Korean Journal of Obstetrics and Gynecology 2000;43(9):1670-1673
No abstract available.
Carcinosarcoma*
;
Female
;
Ovary*
2.A Case of Placental Site Trophoblastic Tumor.
Sun Young LEE ; Hyun Jin PARK ; Seong Pil LEE ; Bong Ju LEE ; Ki Youn HONG ; Heung Gon KIM ; Kie Jung YUN
Korean Journal of Obstetrics and Gynecology 2000;43(6):1123-1126
Placental site trophoblastic tumor(PSTT) is a rare form of gestational trophoblastic disease. This rare tumor has the potential for metastasis and death. The average age at onset of PSTT is 28 years, and the second believed to be postmenopausal at the time of diagnosis. The most common presenting complaint is amenorrhea or abnormal vaginal bleeding and rare complaints are virilization, nephrotic syndrome, uterine rupture, etc. The treatment of choice is surgical removal of the tumor, that is total abdominal hysterectomy with both salpingo-oophorectomy. We present a case of placental site trophoblastic tumor associated with spontaneous uterine rupture that is rare complication with a brief review of literature.
Amenorrhea
;
Diagnosis
;
Female
;
Gestational Trophoblastic Disease
;
Hysterectomy
;
Neoplasm Metastasis
;
Nephrotic Syndrome
;
Trophoblastic Tumor, Placental Site*
;
Trophoblasts
;
Uterine Hemorrhage
;
Uterine Rupture
;
Virilism
3.A Novel Anti-apoptosis Gene, Survivin, Expressed in Uterine Cervical Carcinoma.
Yoon Seok KIM ; Jung Pil LEE ; Jae Ho HAN ; Young Han PARK ; Jong Man RYOU ; Yun Kyoung LIM ; Hee Sug RYU ; Kie Suk OH
Korean Journal of Gynecologic Oncology and Colposcopy 2001;12(3):189-194
OBJECTIVE: Survivin is a novel inhibitor of apoptosis. Suppression of apoptosis is important for carcinogenesis and tumor growth. The purpose of this study was to investigate whether survivin is expressed in the tissues of normal uterine cervix, cervical intraepithelial neoplasia grade III (CIN III) and squamous cell carsinoma of the uterine cervix, as a first step for evaluation of the clinical significance of survivin in uterine cervical cancer. METHODS: We investigated the expression of survivin in the tissues of 11 cases of normal uterine cervix and 14 cases of CIN III and 20 cases of uterine cervical cancer, using Immunohistochemistry at department of obstetrics and gynecology of Ajou university hospital from Jan. 2000 to Jan. 2001 and then compared with the results of three groups. RESULTS: The expression of survivin is increased significantly in cases of CIN III and uterine cervical cancer compared with controls. (p<0.05, One way ANOVA test) CONCLUSION: This study shows survivin could play an important role in the carcinogenesis mechanism of uterine cervix. And further study will be followed to evaluate the clinical relationship of survivin in uterine cervical cancer and whether to act a prognostic factor or not.
Apoptosis
;
Carcinogenesis
;
Cervical Intraepithelial Neoplasia
;
Cervix Uteri
;
Female
;
Gynecology
;
Immunohistochemistry
;
Obstetrics
;
Uterine Cervical Neoplasms
4.A Case of Pleural Metastasis from Papillary Tthyroid Carcinoma.
Jaeheon JEONG ; Sang Yun SHIN ; Myoung Kyun SON ; Young Joo LEE ; Se Hyun KIM ; Jeong Hae KIE ; Yoon Jung CHOI ; Yong Kook HONG ; Chang Hoon HAHN ; Sun Min LEE ; Chong Ju KIM
Tuberculosis and Respiratory Diseases 2007;63(2):188-193
Lung cancer, breast cancer and lymphoma are the common oncologic causes of malignant pleural effusion, comprising more than the half of the causes. However, an endocrinologic carcinoma associated malignant effusion is very rare. Recently, we encountered a case of papillary thyroid carcinoma causing malignant effusion. An 83-year-old female patient presented with dyspnea due to massive pleural effusion in her left side. The pleural biopsy, pleural fluid cytology and breast needle aspiration biopsy results were consistent with a metastatic papillary thyroid carcinoma. Thyroid ultrasonography showed two thyroid masses, but the patient refused a thyroid biopsy. This case highlights the need for considering the possibility of papillary thyroid carcinoma when the cause of malignant pleural effusion cannot be found because one of the rare clinical manifestations of a papillary thyroid carcinoma can be dyspnea due to malignant effusion.
Aged, 80 and over
;
Biopsy
;
Biopsy, Needle
;
Breast
;
Breast Neoplasms
;
Dyspnea
;
Female
;
Humans
;
Lung Neoplasms
;
Lymphoma
;
Needles
;
Neoplasm Metastasis*
;
Pleural Effusion
;
Pleural Effusion, Malignant
;
Thyroid Gland
;
Thyroid Neoplasms
;
Ultrasonography
5.A Case of Pleural Metastasis from Papillary Tthyroid Carcinoma.
Jaeheon JEONG ; Sang Yun SHIN ; Myoung Kyun SON ; Young Joo LEE ; Se Hyun KIM ; Jeong Hae KIE ; Yoon Jung CHOI ; Yong Kook HONG ; Chang Hoon HAHN ; Sun Min LEE ; Chong Ju KIM
Tuberculosis and Respiratory Diseases 2007;63(2):188-193
Lung cancer, breast cancer and lymphoma are the common oncologic causes of malignant pleural effusion, comprising more than the half of the causes. However, an endocrinologic carcinoma associated malignant effusion is very rare. Recently, we encountered a case of papillary thyroid carcinoma causing malignant effusion. An 83-year-old female patient presented with dyspnea due to massive pleural effusion in her left side. The pleural biopsy, pleural fluid cytology and breast needle aspiration biopsy results were consistent with a metastatic papillary thyroid carcinoma. Thyroid ultrasonography showed two thyroid masses, but the patient refused a thyroid biopsy. This case highlights the need for considering the possibility of papillary thyroid carcinoma when the cause of malignant pleural effusion cannot be found because one of the rare clinical manifestations of a papillary thyroid carcinoma can be dyspnea due to malignant effusion.
Aged, 80 and over
;
Biopsy
;
Biopsy, Needle
;
Breast
;
Breast Neoplasms
;
Dyspnea
;
Female
;
Humans
;
Lung Neoplasms
;
Lymphoma
;
Needles
;
Neoplasm Metastasis*
;
Pleural Effusion
;
Pleural Effusion, Malignant
;
Thyroid Gland
;
Thyroid Neoplasms
;
Ultrasonography